265 related articles for article (PubMed ID: 35305641)
1. MALAT1-related signaling pathways in colorectal cancer.
Xu WW; Jin J; Wu XY; Ren QL; Farzaneh M
Cancer Cell Int; 2022 Mar; 22(1):126. PubMed ID: 35305641
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.
Farzaneh M; Najafi S; Dari MAG; Sheykhi-Sabzehpoush M; Dayer D; Cheraghzadeh M; Azizidoost S
Clin Transl Oncol; 2023 Jan; 25(1):48-65. PubMed ID: 36042115
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1-related signaling pathways in osteosarcoma.
Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
[TBL] [Abstract][Full Text] [Related]
4. MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer.
Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
[TBL] [Abstract][Full Text] [Related]
5. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
Jiang X; Li D; Wang G; Liu J; Su X; Yu W; Wang Y; Zhai C; Liu Y; Zhao Z
Oncol Rep; 2020 Apr; 43(4):1245-1255. PubMed ID: 32323831
[TBL] [Abstract][Full Text] [Related]
6. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex.
Ji Q; Zhang L; Liu X; Zhou L; Wang W; Han Z; Sui H; Tang Y; Wang Y; Liu N; Ren J; Hou F; Li Q
Br J Cancer; 2014 Aug; 111(4):736-48. PubMed ID: 25025966
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
[TBL] [Abstract][Full Text] [Related]
9. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.
Yang MH; Hu ZY; Xu C; Xie LY; Wang XY; Chen SY; Li ZG
Biochim Biophys Acta; 2015 Jan; 1852(1):166-74. PubMed ID: 25446987
[TBL] [Abstract][Full Text] [Related]
10.
Arun G; Aggarwal D; Spector DL
Noncoding RNA; 2020 Jun; 6(2):. PubMed ID: 32503170
[TBL] [Abstract][Full Text] [Related]
11. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
12. CD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
14. MALAT1: a potential biomarker in cancer.
Li ZX; Zhu QN; Zhang HB; Hu Y; Wang G; Zhu YS
Cancer Manag Res; 2018; 10():6757-6768. PubMed ID: 30584369
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Long Noncoding RNA MALAT1 in Colorectal Cancer Promotes Radioresistance and Aggressive Malignance.
Shen W; Yu Q; Pu Y; Xing C
Int J Gen Med; 2022; 15():8365-8380. PubMed ID: 36465270
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G
Cell Signal; 2019 May; 57():21-28. PubMed ID: 30716387
[TBL] [Abstract][Full Text] [Related]
17. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.
Xu J; Xiao Y; Liu B; Pan S; Liu Q; Shan Y; Li S; Qi Y; Huang Y; Jia L
J Exp Clin Cancer Res; 2020 Mar; 39(1):54. PubMed ID: 32209115
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA Malat1: Its physiological and pathophysiological functions.
Zhang X; Hamblin MH; Yin KJ
RNA Biol; 2017 Dec; 14(12):1705-1714. PubMed ID: 28837398
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
